The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: ranibizumab     Quarter: 2016Q3

Total Drug/Injury Combinations: 133     Number of Pages: 7

DRUGNAME PT EventCount
Ranibizumab Procedural pain 10 view events
Ranibizumab Back pain 9 view events
Ranibizumab Concomitant disease aggravated 8 view events
Ranibizumab Dry age-related macular degeneration 8 view events
Ranibizumab Metamorphopsia 8 view events
Ranibizumab Neovascular age-related macular degeneration 8 view events
Ranibizumab Retinal degeneration 8 view events
Ranibizumab Vision blurred 8 view events
Ranibizumab Visual field defect 8 view events
Ranibizumab Ankle fracture 7 view events
Ranibizumab Chorioretinal atrophy 7 view events
Ranibizumab Glaucoma 7 view events
Ranibizumab Ocular discomfort 7 view events
Ranibizumab Optic disc disorder 7 view events
RANIBIZUMAB Pneumonia 7 view events
Ranibizumab Retinal exudates 7 view events
RANIBIZUMAB Chronic obstructive pulmonary disease 6 view events
Ranibizumab Hypertension 6 view events
RANIBIZUMAB Pneumothorax 6 view events
Ranibizumab Vitreous floaters 6 view events

Total Drug/Injury Combinations: 133     Number of Pages: 7

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)